Abstract
This study aims to characterize the clinical features of a cohort of patients diagnosed with systemic sclerosis (SSc) after the age of 75 and compare them to a group diagnosed at a younger age. We record the review of 769 patients diagnosed with SSc over the past 16 years. Utilizing a nested case-control model, we compare demographics, disease severity, morbidity, and mortality data of all patients diagnosed after the age of 75 to sex- and disease-type-matched, randomly selected group of patients diagnosed with SSc before the age of 60. Twelve patients were diagnosed with SSc after the age of 75, seven with the diffuse, and five with the limited form. It took longer to diagnose SSc in the older patients, and comparison of disease severity revealed a worse pulmonary picture and a more frequent development of malignancy in the older patients as compared with the younger ones. During a mean follow-up of 36.2 months, our cohort of patients did not have worsening in their disease severity, though 6 months after the last follow-up, six patients died. We conclude that a diagnosis of SSc at an older age appears to be a poor prognostic indicator related to both disease severity and comorbidities. A higher clinical suspicion will lead to an earlier diagnosis and a potential decrease in morbidity and mortality.
Similar content being viewed by others
References
Jimenez SA, Derk CT (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140:37–50
Mayes MD, Reveille JD (2004) Epidemiology, demographics and genetics. In: Clements PJ, Furst DE, (eds) Systemic sclerosis, 2nd ed. Lippincott, Philadelphia, pp 1–15
Hodkinson HM (1971) Scleroderma in the elderly, with special reference to the CRST syndrome. J Am Geriatr Soc 19(3):224–228
Czirjak L, Nagy Z, Szegedi G (1992) Systemic sclerosis in the elderly. Clin Rheumatol 11(4):483–485
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Clements PJ, Medsger TA Jr, Feghali CA (2004) Cutaneous involvement in systemic sclerosis. In: Clements PJ, Furst DE, (eds) Systemic sclerosis, 2nd ed. Lippincott, Philadelphia, pp 129–150
Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26(10):2159–2167
Dalziel JA, Wilcock GK (1979) Progressive systemic sclerosis in the elderly. Postgrad Med J 55:192–193
Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma: a clinical study of 727 cases. Arch Dematol 84:359–371
Medsger TA Jr, Masi AT (1971) Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74:714–721
Laing TJ, Gillespie BW, Toth MB et al (1997) Racial differences in scleroderma among women in Michigan. Arthritis Rheum 40(4):734–742
Silman AJ (1997) Scleroderma-demographics and survival. J Rheumatol 24:58–61 (suppl 48)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Derk, C.T., Artlett, C.M. & Jimenez, S.A. Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study. Clin Rheumatol 25, 831–834 (2006). https://doi.org/10.1007/s10067-005-0177-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0177-y